News & Updates

In what has been dubbed as ‘a small but mighty study’ at ASCO 2022, a phase II trial spearheaded by investigators from Memorial Sloan Kettering Cancer Center in New York, US heralded the remarkable efficacy and safety of the monoclonal antibody dostarlimab for the treatment of locally advanced mismatch repair-deficient (dMMR) rectal cancer.

In hypertensive children undergoing maintenance haemodialysis, ramipril helps improve biomarkers of endothelial dysfunction and inflammation in addition to its blood pressure (BP)-lowering benefits, a study has found.

Once-weekly injection of semaglutide significantly reduced the 10-year risk of developing type 2 diabetes (T2D) among overweight or obese patients, according to a post hoc analysis of the STEP* 1 and 4 trials presented at ADA 2022.

Administration of ampicillin/sulbactam, piperacillin/tazobactam, and ertapenem via intravenous push (IVP) results in better times to initiation of empiric, first-dose antibiotics in the emergency department, (ED) without increasing the incidence of adverse events (AEs), a study has shown.

Epigallocatechin-3-gallate, a catechin that is most potent and abundant in tea, is a potential skin care solution in patients receiving radiotherapy, with a phase II study showing that it helps reduce the incidence and severity of radiation-induced dermatitis.